1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Multiple Indications Cancer: new trials by email Literature Review of Multiple Indications Cancer trials Research Report on Multiple Indications Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib Dasatinib - Multiple Indications Cancer | Phase 2 | Completed | Bristol-Myers Squibb | 17 | 2015-07-31 | 2023-05-06 |
Dasatinib (1)
France (1) · Poland (1)